跳至主要内容
临床试验/EUCTR2006-000516-24-AT
EUCTR2006-000516-24-AT进行中(未招募)不适用

CIPAMI-Study: Clopidogrel administered prehospital to improve primary PCI in Patients with Acute Myocardial Infarction - CIPAMI

Stiftung Institut für Herzinfarktforschung0 个研究点目标入组 654 人开始时间: 2007年8月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
654

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Acute STEMI < 6 hrs.
  • Planned PCI
  • Age 18 years or older
  • Ability to understand the nature, scope, and possible consequences of the study / legal capacity
  • Informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Thrombolytic therapy within 24 hrs.
  • Effective oral or intravenuous anticoagulation
  • Hemorrhagic diathesis
  • Stroke/TIA within 3 months
  • Active gastrointestinal or urogenital bleeding
  • Major surgery (including CABG) within 6 weeks
  • Contraindication to Clopidogrel
  • Pregnancy/Lactation period
  • Women with childbearing potential
  • Treatment with Clopidogrel or Ticlopidine within the last 10 days

研究者

发起方
Stiftung Institut für Herzinfarktforschung

相似试验